Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT02296801
Title A Phase II Randomized Study Evaluating the Biological and Clinical Effects of the Combination of Palbociclib With Letrozole as Neoadjuvant Therapy in Post-Menopausal Women With Estrogen-Receptor Positive Primary Breast Cancer
Recruitment Unknown status
Gender female
Phase Phase II
Variant Requirements Yes
Sponsors NSABP Foundation Inc
Indications

Her2-receptor negative breast cancer

Therapies

Palbociclib

Letrozole

Age Groups: adult
Covered Countries USA | GBR | CAN

Additional content available in CKB BOOST